The pathogenetic role of HLA-B27 and its subtypes

Autoimmunity Reviews

Volumn 6, Issue 3, 2007, Pages 183-189

  Khan, Muhammad Asim ^a   Mathieu, Alessandro ^b   Sorrentino, Rosa ^c   Akkoc, Nurullah ^d  

^a METROHEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Animal models; Ankylosing spondylitis; HLA B27; Pathogenesis

Indexed keywords

AGGRECAN; GENE PRODUCT; HLA ANTIGEN CLASS 1; HLA B27 ANTIGEN; LATENT MEMBRANE PROTEIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN SUBUNIT; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ALLELE; AMINO ACID SEQUENCE; ANKYLOSING SPONDYLITIS; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; GENE MAPPING; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC RISK; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR GENETICS; MOLECULAR MIMICRY; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; POPULATION GENETICS; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; RACE DIFFERENCE; REVIEW; SEQUENCE HOMOLOGY; SPONDYLOARTHROPATHY; STRUCTURAL BIOINFORMATICS; T LYMPHOCYTE;

ANIMALS; DISEASE MODELS, ANIMAL; HLA-B27 ANTIGEN; HUMANS; MODELS, IMMUNOLOGICAL; MOLECULAR MIMICRY; SPONDYLITIS, ANKYLOSING;

EID: 33846642031     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.11.003     Document Type: Review

References (41)

1. Khan M.A. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 7 (1995) 263-269
2. Brown M.A., Kennedy L.G., MacGregor A.J., Darke C., Duncan E., Shatford J.L., et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 40 (1997) 1823-1828
3. Khan M.A., and Ball E.J. Genetic aspects of ankylosing spondylitis. Best Pract Res Clin Rheumatol 16 (2002) 675-690
4. Fiorillo M.T., Cauli A., Carcassi C., Bitti P.P., Vacca A., Passiu G., et al. Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: implications for disease pathogenesis. Arthritis Rheum 48 (2003) 1385-1389
5. Sims A.M., Wordsworth B.P., and Brown M.A. Genetic susceptibility to ankylosing spondylitis. Curr Mol Med 4 (2004) 13-20
6. Zhang G., Luo J., Bruckel J., Weisman M.A., Schumacher H.R., Khan M.A., et al. Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum 50 (2004) 2246-2254
7. Martin T.M., Zhang G., Luo J., Jin L., Doyle T.M., Rajska B.M., et al. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum 52 (2005) 269-274
8. Hammer R.E., Maika S.D., Richardson J.A., Tang J.P., and Taurog J.D. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 63 (1990) 1099-1112
9. Tran T.M., Dorris M.L., Satumtira N., Richardson J.A., Hammer R.E., Shang J., et al. Additional human beta2m curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27 transgenic rats. Arthritis Rheum 54 (2006) 1317-1327
10. Madden D.R., Gorga J.C., Strominger J.L., and Wiley D.C. The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70 (1992) 1035-1048
11. den Uyl D., van der Horst-Bruinsma I.E., and van Agtmael M. Progression of HIV to AIDS: a protective role for HLA-B27?. AIDS Rev 6 (2004) 89-96
12. Lopez de Castro J.A. HLA-B27-portraying immunodominant viral epitopes. Eur J Immunol 35 (2005) 336-340
13. Benjamin R., and Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 11 (1990) 137-142
14. Hermann E., Yu D.T., Meyer zum Buschenfelde K.H., and Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 342 (1993) 646-650
15. Khan M.A. Update: the twenty subtypes of HLA-B27. Curr Opin Rheumatol 12 (2000) 235-238
16. Akkoc N., and Khan M.A. HLA-B27 and ankylosing spondylitis. APLAR J Rheumatol 8 (2005) 146-153
17. Lopez de Castro J.A., Alvarez I., Marcilla M., Paradela A., Ramos M., Sesma L., et al. HLA-B27: a registry of constitutive peptide ligands. Tissue Antigens 63 (2004) 424-445
18. Khan M.A. Update on spondyloarthropathies. Ann Intern Med 136 (2002) 896-907
19. Paladini F., Taccari E., Fiorillo M.T., Cauli A., Passiu G., Mathieu A., et al. Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies. Arthritis Rheum 52 (2005) 3319-3321
20. Fiorillo MT, Maragno M, Butler R, Dupuis ML, Sorrentino R. CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J Clin Invest 106: 47-53.
21. Arthritis Rheum 52 (2005) 3319-3321
22. *2706) differ by specific changes at three anchor positions. J Biol Chem 277 19 (2002) 16744-16779
23. *2709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability. J Biol Chem 277 32 (2002) 28749-28756
24. Hulsmeyer M., Fiorillo M.T., Bettosini F., Sorrentino R., Saenger W., Ziegler A., et al. Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J Exp Med 199 (2004) 271-281
25. Fiorillo M.T., Ruckert C., Hulsmeyer M., Sorrentino R., Saenger W., Ziegler A., et al. Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. J Biol Chem 280 (2005) 2962-2971
26. Ruckert C., Fiorillo M.T., Loll B., Moretti R., Biesiadka J., Saenger W., et al. Conformational dimorphism of self-peptides and molecular mimicry in a disease-associated HLA-B27 subtype. J Biol Chem 281 (2006) 2306-2316
27. Starikov E.B., Nilsson L., and Hulsmeyer M. A single residue exchange between two HLA-B27 alleles triggers increased peptide flexibility. Eur Biophys J 33 7 (Nov 2004) 651-655
28. Ramos M., Alvarez I., Sesma L., Logean A., Rognan D., and Lopez de Castro J.A. Molecular mimicry of an HLA-B27 derived ligand of arthritis-linked subtypes with Chlamydia proteins. J Biol Chem 277 (2002) 37573-37581
29. Kuon W., Kuhne M., Busch D.H., Atagunduz P., Seipel M., Wu P., et al. Identification of novel human aggrecan T cell epitopes in HLA-B27 transgenic mice associated with spondyloarthropathy. J Immunol 173 8 (2004) 4859-4866
30. Atagunduz P., Appel H., Kuon W., Wu P., Thiel A., Kloetzel P.M., et al. HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis. Arthritis Rheum 52 (2005) 892-901
31. Colbert R.A. The immunobiology of HLA-B27: variations on a theme. Curr Mol Med 4 (2004) 21-30
32. Kollnberger S., Bird L.A., Roddis M., Hacquard-Bouder C., Kubagawa H., Bodmer H.C., et al. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol 173 (2004) 1699-1710
33. Turner M.J., Sowders D.P., DeLay M.L., Mohapatra R., Bai S., Smith J.A., et al. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J Immunol 175 (2005) 2438-2448
34. Taurog J.D., Maika S.D., Simmons W.A., Breban M., and Hammer R.E. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 150 (1993) 4168-4178
35. Cauli A., Dessole G., Fiorillo M.T., Vacca A., Mameli A., Bitti P., et al. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27 positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology (Oxford) 41 (2002) 1375-1379
36. McMichael A., and Bowness P. HLA-B27: natural function and pathogenic role in spondyloarthritis. Arthritis Res 4 Suppl 3 (2002) S153-S158
37. Boyle L.H., Goodall J.C., and Gaston J.S. Major histocompatibility complex class I-restricted alloreactive CD4+ T cells. Immunology 112 (2004) 54-63
38. Luthra-Guptasarma M., and Singh B. HLA-B27 lacking associated β2-microglobulin rearranges to auto-display or cross-display residues 169-181: a novel molecular mechanism for spondyloarthropathies. FEBS Lett 24 575 (2004) 1-8
39. Uchanska-Ziegler B., and Ziegler A. Ankylosing spondylitis: a beta2m-deposition disease?. Trends Immunol 24 (2003) 73-76
40. Penttinen M.A., Heiskanen K.M., Mohapatra R., DeLay M.L., Colbert R.A., Sistonen L., et al. Enhanced intracellular replication of Salmonella enteritidis in HLA-B27-expressing human monocytic cells: dependency on glutamic acid at position 45 in the B pocket of HLA-B27. Arthritis Rheum 50 (2004) 2255-2263
41. Rudwaleit M., Siegert S., Yin Z., Eick J., Thiel A., Radbruch A., et al. Low T cell production of TNF-alpha and IFN-gamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 60 (2001) 36-42